Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non‐Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population‐Based Cohort Study

Taiwan’s National Health Insurance Research Database: past and future

(2019) Cheng-Yang Hsieh et al.   Clinical Epidemiology

Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort

(2019) Dongmin Kim et al.   EUROPEAN HEART JOURNAL

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study

(2019) Mette Søgaard et al.   Journal of the American Heart Association

Efficacy of Warfarin Anticoagulation and Incident Dementia in a Community-Based Cohort of Atrial Fibrillation

(2018) Malini Madhavan et al.   MAYO CLINIC PROCEEDINGS

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation

(2018) Wesley T. O'Neal et al.   Journal of the American Heart Association

Antithrombotic Therapy for Atrial Fibrillation

(2018) Gregory Y.H. Lip et al.   CHEST

Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States

(2018) Christine L. Baker et al.   ADVANCES IN THERAPY

Cognitive dysfunction in atrial fibrillation

(2018) Malini Madhavan et al.   Nature Reviews Cardiology

Atrial fibrillation, antithrombotic treatment, and cognitive aging

(2018) Mozhu Ding et al.   NEUROLOGY

Non-vitamin K Antagonist Oral Anticoagulants and Cognitive Impairment in Atrial Fibrillation: Insights From the Meta-Analysis of Over 90,000 Patients of Randomized Controlled Trials and Real-World Studies

(2018) Chi Zhang et al.   Frontiers in Aging Neuroscience

Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation

(2018) Nemin Chen et al.   Journal of the American Heart Association

Does atrial fibrillation cause cognitive decline and dementia?

(2017) Joanna Dietzel et al.   EUROPACE

Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study

(2017) Laila Staerk et al.   EUROPEAN HEART JOURNAL

Less dementia with oral anticoagulation in atrial fibrillation

(2017) Leif Friberg et al.   EUROPEAN HEART JOURNAL

Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study

(2017) So-Ryoung Lee et al.   PLoS One

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation

(2016) Victoria Jacobs et al.   AMERICAN JOURNAL OF CARDIOLOGY

New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events

(2015) Agon Mekaj et al.   Therapeutics and Clinical Risk Management

Use of Coumarin Anticoagulants and Cerebral Microbleeds in the General Population

(2014) Saloua Akoudad et al.   STROKE

Areca Nut Chewing and Risk of Atrial Fibrillation in Taiwanese Men: A Nationwide Ecological Study

(2013) Wei-Chung Tsai et al.   International Journal of Medical Sciences

Competing Risks Regression for Stratified Data

(2010) Bingqing Zhou et al.   BIOMETRICS

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST